Browse studies

Find your next paid study

27,333 recruiting studies available now

WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

The WE-TRUST study is a multi-center randomized clinical trial to assess the impact of a Direct to Angio Suite (DTAS) workflow on stroke patient outcomes.

Stroke, Acute

Estimated

~$10 – $750

Actual pay is set by the research site.

Philips Clinical & Medical Affairs GlobalNCT04701684

Sleep Health in the Rural South and Its Relationships With Cardiometabolic Health Disparities

Rural communities in the southern U.S. suffer a disproportionate burden of morbidity and mortality from cardiometabolic disease, with traditional risk factors …

Sleep ApneaInsomniaSleep Deprivation+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Brigham and Women's HospitalNCT06336525

Observational

TeleYoga for Chronic Low Back Pain: A Quantitative and Qualitative Study

Chronic low back pain (CLBP) is a highly prevalent and debilitating condition, affecting 84% of the population over a lifetime1. CLBP is the leading cause of d…

Low Back Pain

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Taylor ReesNCT07216417

Phase 2

A Prospective, Randomized, Single-Blind Phase 2a Multi-Center Dose Comparative Study to Evaluated The Safety, Tolerability, and Antimicrobial Efficacy Of Topically Twice Daily Applied Bisphosphocin Nu-3 Gel At a 2%, 5%, And 10% Concentration To Infected Diabetic Foot Ulcers (iDFU)

The goal of this clinical trial is to learn if drug Nu-3 works to treat mildly infected diabetic foot ulcers in adults with Type 1 or Type 2 diabetes at 3 diff…

Diabetic Foot Ulcers (DFUs)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Lakewood-Amedex IncNCT07565506

Phase 2

A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With Persistent Corneal Epithelial Defects (NEXPEDE-1)

This study is to evaluate the safety and efficacy of NEXAGON® (lufepirsen ophthalmic gel) (NEXAGON) in subjects with persistent corneal epithelial defects (PCE…

Persistent Corneal Epithelial Defect

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Glaukos CorporationNCT05966493

Biomarkers in Friedreich's Ataxia

The purpose of this project is to characterize measures of cardiac performance and neuromuscular physiology in FA patients using novel techniques, including ec…

Friedreich's Ataxia

Estimated

~$10 – $750

Actual pay is set by the research site.

University of FloridaNCT02497534

Observational

Effect of Glucagon on Fasting Insulin Secretion and Glucose Metabolism in Subjects Without Type 2 Diabetes

Fasting hyperglycemia contributes disproportionately to nonenzymatic glycosylation and the microvascular complications of type 2 diabetes. However, little is k…

PreDiabetes

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT06424106

Observational

The Immediate and 24-hour Effects of Body Tempering Versus Foam Rolling on Lower Extremity Muscular Power During the Vertical Jump and Standing Long Jump Tests

The goal of this clinical trial is to examine the effects of body tempering on healthy volunteers between the ages of 18-39. The main question it aims to answe…

Lower Extremity Muscular Power Performance Output

Estimated

~$10 – $750

Actual pay is set by the research site.

University of South CarolinaNCT06646926

Phase 3

Loop Diuretics During Morcellation to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)

Holmium Laser Enucleation of the Prostate (HoLEP) is a size-independent treatment option for benign prostatic hypertrophy (BPH) as recommended by the American …

BPH With Urinary ObstructionBPHHematuria+1 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Northwestern UniversityNCT05620784

Heart Attack Research Program: Platelet Sub-Study (HARP); Platelet Collection for Patients With Myocardial Infarction

This prospective observational cohort study, will investigate the platelet phenotype, platelet genetic composition, and role of platelets as effector cells in …

Myocardial Infarction

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NYU Langone HealthNCT03022552

Phase 1

Emicizumab for Severe VON Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease (VWD) is the most common inherited bleeding disorder affecting up to 0.1% of the population, is usually characterized by mucocutaneous b…

Von Willebrand Disease, Type 3Concomitant VWD and Hemophilia

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Bleeding and Clotting Disorders Institute Peoria, IllinoisNCT05500807

Phase 3

A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination With Trastuzumab and Chemotherapy (XELOX) Versus Trastuzumab and Chemotherapy (XELOX) With or Without Pembrolizumab for the First Line Treatment of Locally Advanced or Metastatic Gastroesophageal Junction and Gastric Cancer

This is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with t…

Gastroesophageal-junction CancerMonoclonal AntibodyGastric Cancer+1 more

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Shanghai Henlius BiotechNCT06532006